ClinicalTrials.govpublic full text
Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival
leukemia, myeloid, acute, measurable residual disease, surrogate endpoint, multiparameter flow cytometry, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 870935
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.